Sponsor Pipeline

Shanghai Xinzhi BioMed Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
2
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 2/3
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT06111638 Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs Hemophilia A Recruiting
NCT05203679 Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug Hemophilia B Active, Not Recruiting
Phase 1
NCT07195825 A Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 in the Treatment of… PD Recruiting
Disease Areas
Hemophilia (2)
Get alerts when Shanghai Xinzhi BioMed Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free